MedPath

nani formulation for Chronic Eczema

Phase 2
Conditions
Health Condition 1: L309- Dermatitis, unspecified
Registration Number
CTRI/2021/01/030759
Lead Sponsor
ATIONAL INSTITUTE OF UNANI MEDICINE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS WHO WILL GIVE CONSENT AND ABLE TO DO FOLLOW UP

Exclusion Criteria

1.Patients below 18 and above 60 years of age.

2.Pregnant and lactating women.

3.Patients having local wound and other skin diseases.

4.Patients suffering from systemic illnesses like Diabetes Mellitus, Malignancy

5.Patients of Acute Eczema of 2 weeks with vesicles and oozing, Seborrhoeic Dermatitis, Stasis Dermatitis, Psoriasis and Exfoliative Dermatitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath